CCRN vs. MD, TBI, KELYA, BBSI, HQI, SRT, LH, DGX, DVA, and CHE
Should you be buying Cross Country Healthcare stock or one of its competitors? The main competitors of Cross Country Healthcare include Pediatrix Medical Group (MD), TrueBlue (TBI), Kelly Services (KELYA), Barrett Business Services (BBSI), HireQuest (HQI), Startek (SRT), Laboratory Co. of America (LH), Quest Diagnostics (DGX), DaVita (DVA), and Chemed (CHE).
Cross Country Healthcare (NASDAQ:CCRN) and Pediatrix Medical Group (NYSE:MD) are both small-cap business services companies, but which is the better stock? We will compare the two companies based on the strength of their risk, institutional ownership, analyst recommendations, media sentiment, earnings, dividends, valuation, community ranking and profitability.
Pediatrix Medical Group received 31 more outperform votes than Cross Country Healthcare when rated by MarketBeat users. However, 65.14% of users gave Cross Country Healthcare an outperform vote while only 61.20% of users gave Pediatrix Medical Group an outperform vote.
Cross Country Healthcare has higher revenue and earnings than Pediatrix Medical Group. Pediatrix Medical Group is trading at a lower price-to-earnings ratio than Cross Country Healthcare, indicating that it is currently the more affordable of the two stocks.
Cross Country Healthcare has a beta of 0.74, meaning that its stock price is 26% less volatile than the S&P 500. Comparatively, Pediatrix Medical Group has a beta of 1.54, meaning that its stock price is 54% more volatile than the S&P 500.
In the previous week, Pediatrix Medical Group had 6 more articles in the media than Cross Country Healthcare. MarketBeat recorded 9 mentions for Pediatrix Medical Group and 3 mentions for Cross Country Healthcare. Cross Country Healthcare's average media sentiment score of 0.55 beat Pediatrix Medical Group's score of 0.50 indicating that Cross Country Healthcare is being referred to more favorably in the media.
96.0% of Cross Country Healthcare shares are held by institutional investors. Comparatively, 97.7% of Pediatrix Medical Group shares are held by institutional investors. 4.9% of Cross Country Healthcare shares are held by insiders. Comparatively, 2.0% of Pediatrix Medical Group shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.
Cross Country Healthcare has a net margin of 2.58% compared to Pediatrix Medical Group's net margin of -3.53%. Cross Country Healthcare's return on equity of 11.69% beat Pediatrix Medical Group's return on equity.
Cross Country Healthcare presently has a consensus target price of $20.83, indicating a potential upside of 41.72%. Pediatrix Medical Group has a consensus target price of $9.10, indicating a potential upside of 26.39%. Given Cross Country Healthcare's stronger consensus rating and higher probable upside, equities research analysts clearly believe Cross Country Healthcare is more favorable than Pediatrix Medical Group.
Summary
Cross Country Healthcare beats Pediatrix Medical Group on 13 of the 18 factors compared between the two stocks.
Get Cross Country Healthcare News Delivered to You Automatically
Sign up to receive the latest news and ratings for CCRN and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding CCRN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Cross Country Healthcare Competitors List
Related Companies and Tools
